NCT05657912 - Cara CDRS (Conduction Disturbance Risk Score) 1.0 | Biotech Hunter

Enrollment

355

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

Transcatheter Aortic Valve Replacement

Interventions

DEVICE

ECG monitoring

Continuous ECG monitoring of Conduction Disturbances in patients undergoing TAVR procedure

Trial Locations (3)

Policlinico San Donato, Milan

Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval, Québec

Hospital Clínic de Barcelona, Barcelona